UNSPSC 51453702: Becanthone

This classification denotes an antiparasitic agent with the molecular formula C22H28N2O2S, chemically known as 1-((2-(Ethyl(2-hydroxy-2-methylpropyl)amino)ethyl)amino)-4-methylthioxanthen-9-one but generally known as becanthone, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A6P8OYN3G5. The term becanthone is a United States Adopted Name designation. As of Q4 2014, BECANTHONE remains the US FDA Preferred Term for this commodity. Becanthone bears US NLM identifiers UMLS ID C2698337 and NCI Concept Code C79918.

SMILES: CCN(CCNC1=C2C(=C(C=C1)C)SC3=CC=CC=C3C2=O)CC(C)(C)O.

UNSPSC 51453702 Becanthone, a Commodity code, represents pharmaceutical products and medical supplies that state and local governments procure for public health, emergency response, and community health initiatives. Recent state and local solicitations under this code show purchases of specific pharmaceutical agents and medical countermeasures — notably naloxone for overdose reversal and drug deactivation systems for controlled-substance disposal. The issuing bodies include state departments of public health and county health authorities, typically buying through competitive bidding processes, piggyback arrangements with multi-state purchasing consortia, or direct IFB awards. These procurement vehicles reflect the mission-critical and budget-constrained nature of public health procurement, where agencies leverage cooperative purchasing agreements to access pre-negotiated pricing and expedite delivery of life-safety pharmaceuticals and medical devices.

Recent activity spans at least two states. The Illinois Department of Public Health awarded a $2,999,999.11 contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026 for pharmaceutical warehouse supply, while Seminole County, Florida issued an IFB in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The Seminole County procurement specified an initial two-year term with one-year renewal option, e-procurement submission, and compliance with federal regulations including potential FEMA funding requirements. Both opportunities demonstrate state and local demand for pharmaceutical products aligned with opioid-response and emergency-preparedness objectives, with multi-year contracts and recurring annual volumes typical of the category.